How to optimize the treatment of early stage Parkinson’s disease

作     者：Fabrizio Stocchi Laura Vacca Fabiana G Radicati 

作者机构：Department of NeurologyInstitute for Research and Medical CareIRCCS San Raffaelevia della Pisana 23500163 RomeItaly 

出 版 物：《Translational Neurodegeneration》 (转化神经变性病（英文）)

年 卷 期：2015年第4卷第1期

页      面：26-32页

核心收录：

学科分类：1002[医学-临床医学] 10[医学] 

基　　金：GSK Teva Boehringer Ingelheim Newron Merck Serono Novartis Lundbeck Impax Schering Plough MSD UCB 

主　　题：drugs diagnosis treatment 

摘      要：The approach to early Parkinson’s disease denotes the communication of the diagnosis and important decisions,such as when and how to start *** based medicine and guidelines indicate which drugs have robust evidence of efficacy and tolerability in this specific ***,de-novo patients may show different characteristics and they may be in a different phase of their *** this review,we will give an insight into the appropriate time therapy should be started and the actual knowledge about disease modification ***,the drugs indicated for early treatment will be considered and an indication for the use of these drugs will be given with the support of the actual knowledge.